Skin temperature prediction model parameters. by Miho Iwasaki (22553084)

“…Herein, 28 healthy individuals were repeatedly moved between two temperature environments, and their psychological/physiological responses to temperature differences in the environment were recorded [T_26-26 (control), T_26-31 (5 °C step), T_26-36 (10 °C step), and T_21-36 (15 °C step)]. …”

HF model parameters. by Miho Iwasaki (22553084)

“…Herein, 28 healthy individuals were repeatedly moved between two temperature environments, and their psychological/physiological responses to temperature differences in the environment were recorded [T_26-26 (control), T_26-31 (5 °C step), T_26-36 (10 °C step), and T_21-36 (15 °C step)]. …”

HR model parameters. by Miho Iwasaki (22553084)

“…Herein, 28 healthy individuals were repeatedly moved between two temperature environments, and their psychological/physiological responses to temperature differences in the environment were recorded [T_26-26 (control), T_26-31 (5 °C step), T_26-36 (10 °C step), and T_21-36 (15 °C step)]. …”

LF/HF model parameters. by Miho Iwasaki (22553084)

“…Herein, 28 healthy individuals were repeatedly moved between two temperature environments, and their psychological/physiological responses to temperature differences in the environment were recorded [T_26-26 (control), T_26-31 (5 °C step), T_26-36 (10 °C step), and T_21-36 (15 °C step)]. …”

LF/HF prediction model parameters. by Miho Iwasaki (22553084)

“…Herein, 28 healthy individuals were repeatedly moved between two temperature environments, and their psychological/physiological responses to temperature differences in the environment were recorded [T_26-26 (control), T_26-31 (5 °C step), T_26-36 (10 °C step), and T_21-36 (15 °C step)]. …”

HR prediction model parameters. by Miho Iwasaki (22553084)

“…Herein, 28 healthy individuals were repeatedly moved between two temperature environments, and their psychological/physiological responses to temperature differences in the environment were recorded [T_26-26 (control), T_26-31 (5 °C step), T_26-36 (10 °C step), and T_21-36 (15 °C step)]. …”

Flowchart of the steps involved in the high-throughput exoproteome screening assay (HESA). by Marion Schoof (11999106)

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Vitamin C decreases the obesogenic and hyperglycemic effect of invert sugar in prediabetic rats by Patrícia MOLZ (6744857)

“…Methods: One hundred-day-old Male Wistar rats with a mean weight of 336.58±23.43g were randomly assigned to the following groups: (1) control, receiving water (C); (2) invert sugar control, receiving a 32% watery solution of invert sugar; (3) vitamin C control, receiving a watery solution of vitamin C (60mg/L), and (4) vitamin C plus invert sugar, receiving a watery solution of vitamin C and invert sugar. …”

Raw data of the charts in Fig 5. by Kam Pui Tam (19746865)

“…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …”

Fig 2 - by Dania Abuleil (10098462)

The relationship between experimental and predicted ΔΔG of ACE2 mutants and relative SARS-CoV-2 pseudotype infectivity reported by Shukla et al [38]. by Stuart A. MacGowan (11326845)

Subjects:

GSK343 decreased tumor stemness. by Laura V. Bownes (10276762)

“…(C) COA6 cells were treated with GSK343 (0, 5 μM) for 72 hours. qPCR demonstrated a significant decrease in mRNA abundance of known stemness markers Oct4, Nanog, and Sox2 following GSK343 treatment compared to untreated cells. …”

Combination of cAMP-enhancing and cAMP-inhibiting neuromodulation can increase or decrease the AP threshold throughout the apical dendrite in the Hay-model L5PC. by Tuomo Mäki-Marttunen (388882)

3D interactions between the ligand and the protein_DNA complex in the first (C1) and second (C2) clusters. by Ahmed A. Gaber (13302308)

Subjects:

Bifurcation diagram of <i>z</i> with parameter <i>c</i>₂. by Xinghua Fan (7344632)